David Schnell's Net Worth
$30.8 Million
Who is David Schnell?
David Schnell has an estimated net worth of $30.8 Million. This is based on reported shares across multiple companies, which include Vitae Pharmaceuticals, Inc, TERCICA INC, Vanda Pharmaceuticals Inc., AMICUS THERAPEUTICS INC, HANSEN MEDICAL INC, KYTHERA BIOPHARMACEUTICALS INC, NGM BIOPHARMACEUTICALS INC, Trubion Pharmaceuticals, Inc, INFINITY PHARMACEUTICALS, INC., SENOMYX INC, and BAXANO SURGICAL, INC..
SEC CIK
David Schnell's CIK is 0001162060
Past Insider Trading and Trends
2004 was David Schnell's most active year for acquiring shares with 10 total transactions. David Schnell's most active month to acquire stocks was the month of May. 2007 was David Schnell's most active year for disposing of shares, totalling 16 transactions. David Schnell's most active month to dispose stocks was the month of May. 2014 saw David Schnell paying a total of $5,374,456.00 for 2,913,680 shares, this is the most they've acquired in one year. In 2007 David Schnell cashed out on 4,067,311 shares for a total of $96,405.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TERCICA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.98% | -877.22K |
—
|
—
| 2.94M |
Sep 2
| |||
Form 4
|
∞
| 3.82M |
$9.00 | $4,999,995.00 | 3.82M |
Mar 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -38.34% | -921.15K |
—
|
—
| 1.48M |
Nov 3
| |||
Form 4
|
∞
| 2.4M |
—
|
—
| 2.4M |
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $12.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.24M |
$10.69 | -$96,405.00 | 2.24M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HANSEN MEDICAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.34% | -900.00K |
—
|
—
| 1.39M |
Nov 2
| |||
Form 4
| -13.44% | -355.33K |
—
|
—
| 2.29M |
May 30
| |||
Form 4
| -17.44% | -558.38K |
—
|
—
| 2.64M |
May 21
| |||
Form 4
|
∞
| 3.2M |
—
|
—
| 3.2M |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vitae Pharmaceuticals, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.16% | -859.67K |
—
|
—
| 1.73M |
Mar 24
| |||
Form 4
| +814.85% | 2.91M |
$8.00 |
—
| 3.26M |
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||